Alignment Healthcare, Inc.
ALHC
$15.80
$0.785.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 49.69% | 49.34% | 48.36% | 43.31% | 36.80% |
| Total Other Revenue | 30.56% | 31.79% | 39.36% | 58.36% | 127.14% |
| Total Revenue | 49.46% | 49.12% | 48.25% | 43.47% | 37.46% |
| Cost of Revenue | 46.98% | 47.52% | 48.33% | 44.35% | 37.93% |
| Gross Profit | 70.27% | 62.63% | 47.59% | 36.34% | 33.69% |
| SG&A Expenses | 15.48% | 16.75% | 19.99% | 16.00% | 14.72% |
| Depreciation & Amortization | 16.82% | 21.30% | 22.69% | 27.64% | 23.41% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.08% | 42.56% | 43.59% | 39.51% | 33.82% |
| Operating Income | 84.16% | 54.49% | 22.96% | 10.56% | 7.93% |
| Income Before Tax | 68.64% | 42.31% | 13.59% | 8.57% | 6.07% |
| Income Tax Expenses | 162,300.00% | 282.61% | 195.45% | -105.75% | -100.59% |
| Earnings from Continuing Operations | 66.51% | 42.27% | 13.57% | 8.67% | 6.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 145.45% | 80.49% | -76.92% | -62.39% | -49.49% |
| Net Income | 66.65% | 42.37% | 13.50% | 8.60% | 6.21% |
| EBIT | 84.16% | 54.49% | 22.96% | 10.56% | 7.93% |
| EBITDA | 107.39% | 70.09% | 32.72% | 17.25% | 12.86% |
| EPS Basic | 66.89% | 43.50% | 15.43% | 11.09% | 8.96% |
| Normalized Basic EPS | 73.36% | 47.84% | 19.67% | 9.26% | 7.82% |
| EPS Diluted | 65.95% | 43.00% | 14.90% | 10.60% | 8.49% |
| Normalized Diluted EPS | 72.70% | 47.84% | 19.67% | 9.26% | 7.82% |
| Average Basic Shares Outstanding | 2.60% | 2.28% | 2.47% | 2.79% | 2.97% |
| Average Diluted Shares Outstanding | 4.08% | 2.28% | 2.47% | 2.79% | 2.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |